OrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentDisciplines and OccupationsHealth Care
ChromoblastomycosisPhialophoraAscomycotaMitosporic FungiItraconazoleExophialaPotassium IodideAntifungal AgentsCarcinoma, Basal CellDermatologyCross-Sectional StudiesSkin NeoplasmsTattooingPhotosensitivity DisordersMeningitis, Aseptic

Beneficial effects of HIV peptidase inhibitors on Fonsecaea pedrosoi: promising compounds to arrest key fungal biological processes and virulence. (25/59)

 (+info)

Secretion of five extracellular enzymes by strains of chromoblastomycosis agents. (26/59)

 (+info)

Cladophialophora carrionii: a rare agent of chromoblastomycosis in Rio de Janeiro State, Brazil. (27/59)

 (+info)

Monocyte-derived dendritic cells from patients with severe forms of chromoblastomycosis induce CD4+ T cell activation in vitro. (28/59)

 (+info)

In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. (29/59)

 (+info)

Verrucous plaque on the face: what is your diagnosis? (30/59)

A 46-year-old male patient presented with hyperpigmented verrucous plaques and papules mainly on the left cheek and malar region that had evolved over a 7 month period. Histopathology demonstrated the presence of a large number of classical copper penny bodies or muriform bodies and a predominantly neutrophilic dermal infiltrate that confirmed the diagnosis of chromoblastomycosis.  (+info)

Chromoblastomycosis associated with a lethal squamous cell carcinoma. (31/59)

 (+info)

Chromoblastomycosis: study of 27 cases and review of medical literature. (32/59)

 (+info)